Stay updated with breaking news from Curtisa Lockshin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Josh Beckerman Shares of cancer-focused Xenetic Biosciences were down 15% to $3.56 Wednesday following a presentation during the Virtual Investor Summer...
Live video webcast with moderated roundtable with members of the Xenetic leadership team and recognized oncology leader and NETs researcher, Jonathan Spicer, MD, PhD on Wednesday, March 29th at 11:00 AM
- Live moderated video webcast with members of the Xenetic leadership team and recognized oncology leader and NETs researcher, Jonathan Spicer, MD, PhD on Wednesday, March 29th at 11:00 AM ET -FRENCHTOWN
- Live video webcast with moderated roundtable with members of the Xenetic leadership team and surgical oncology Key Opinion Leader, Allan Tsung, MD on Thursday, June 9th at 11:00 AM ET -FRENCHTOWN, NJ
Live Video Webcast With Moderated Roundtable With Members of the Xenetic Leadership Team and Surgical Oncology Key Opinion Leader, Allan Tsung, MD on Thursday, June 9th at 11:00 AM ETFRAMINGHAM, MA / ACCESSWIRE